bioavailability

Nanoforming

In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.

News

Hovione Expands Particle Design Solutions to Solve Bioavailability

Topics • Chemistry

Hot Melt Extrusion Technology (HME)

Top-Feature

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

BASF SE

Nanoform

bioavailability

Nanoforming

Hovione Expands Particle Design Solutions to Solve Bioavailability

Hot Melt Extrusion Technology (HME)

Top-Feature

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Newsletter & e-edition